Literature DB >> 27075615

Prediction of Infarct Transmurality From C-Reactive Protein Level and Mean Platelet Volume in Patients With ST-Elevation Myocardial Infarction: Comparison of the Predictive Values of Cardiac Enzymes.

DongHun Kim1, Dong-Hyun Choi2, Bo-Bae Kim3, Seo-Won Choi3, Keun Ho Park3, Heesang Song4.   

Abstract

BACKGROUND: High C-reactive protein (CRP) and mean platelet volume (MPV) levels are associated with poor prognosis in patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study was to evaluate the relationship between CRP level or MPV and infarct transmurality in patients with STEMI.
METHODS: We retrospectively reviewed CRP level, MPV, and infarct transmurality in 112 STEMI patients who were assessed with contrast-enhanced cardiac magnetic resonance imaging.
RESULTS: When the cut-off peak CRP level and MPV were set at 2.35 mg/dl and 7.3 fl using receiver operating characteristic curves analysis, the sensitivity was 67.3/69.2% and specificity was 76.7/76.7% for differentiating between the groups with and those without transmural involvement. Peak CRP level, MPV, peak creatine kinase-MB (CK-MB) level, and peak high-sensitivity cardiac troponin T (hs-cTnT) level had comparable predictive values for transmural involvement (area under the curve, 0.749, 0.761, 0.680, and 0.696, respectively). High peak CRP level and MPV were independent predictors of transmural involvement after adjusting for the peak CK-MB level, peak hs-cTnT level, baseline thrombolysis in myocardial infarction flow grade, and left ventricular ejection fraction (odds ratio: 5.16/5.42, 95% confidence interval: 1.84-14.50/2.03-14.47, P = 0.002/0.001, respectively) in the logistic regression analysis.
CONCLUSION: The results of this study show that peak CRP level and MPV are predictive markers for transmural involvement. Their predictive power for transmural involvement is independent of and comparable to that of peak CK-MB and hs-cTnT levels.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  C-reactive protein; magnetic resonance imaging; mean platelet volume; myocardial infarction

Mesh:

Substances:

Year:  2016        PMID: 27075615      PMCID: PMC6807005          DOI: 10.1002/jcla.21959

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  53 in total

Review 1.  Platelets in atherothrombosis.

Authors:  Zaverio M Ruggeri
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

2.  Clinical outcome prediction from mean platelet volume in patients undergoing percutaneous coronary intervention in Korean cohort: Implications of more simple and useful test than platelet function testing.

Authors:  Seo-Won Choi; Dong-Hyun Choi; Hyun-Wook Kim; Yo-Han Ku; Sung-Il Ha; Geon Park
Journal:  Platelets       Date:  2013-08-02       Impact factor: 3.862

3.  Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease.

Authors:  Georg Slavka; Thomas Perkmann; Helmuth Haslacher; Stefan Greisenegger; Claudia Marsik; Oswald F Wagner; Georg Endler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-02-17       Impact factor: 8.311

4.  Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment.

Authors:  K O Pietilä; A P Harmoinen; J Jokiniitty; A I Pasternack
Journal:  Eur Heart J       Date:  1996-09       Impact factor: 29.983

5.  Specific removal of C-reactive protein by apheresis in a porcine cardiac infarction model.

Authors:  Anna Christine Slagman; Christopher Bock; Hassan Abdel-Aty; Birgit Vogt; Frank Gebauer; Gunnar Janelt; Franziska Wohlgemuth; Rene Morgenstern; Gülcan Yapici; Astrid Puppe; Diethelm Modersohn; Dörte Mans; Timo Jerichow; Sascha Ott; Rudolf Kunze; Wieland Schrödl; Christina Janko; Martin Hermann; Joachim R Kalden; Peter Kern; Hans Parsch; Michael Kirschfink; Jeanette Schulz-Menger; Rainer Röttgen; Juliane K Unger; Ulrich Frei; Ralf Schindler; Martin Möckel; Ahmed Sheriff
Journal:  Blood Purif       Date:  2010-12-07       Impact factor: 2.614

6.  Acute phase proteins in patients with acute coronary syndrome: Correlations with diagnosis, clinical features, and angiographic findings.

Authors:  Natale Daniele Brunetti; Michele Correale; Pier Luigi Pellegrino; Andrea Cuculo; Matteo Di Biase
Journal:  Eur J Intern Med       Date:  2007-03       Impact factor: 4.487

7.  Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein.

Authors:  Mahmoud Suleiman; Rania Khatib; Yoram Agmon; Riad Mahamid; Monther Boulos; Michael Kapeliovich; Yishai Levy; Rafael Beyar; Walter Markiewicz; Haim Hammerman; Doron Aronson
Journal:  J Am Coll Cardiol       Date:  2006-03-07       Impact factor: 24.094

8.  Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction.

Authors:  Bernhard L Gerber; Jérôme Garot; David A Bluemke; Kathérine C Wu; João A C Lima
Journal:  Circulation       Date:  2002-08-27       Impact factor: 29.690

9.  C-reactive protein and heart failure after myocardial infarction in the community.

Authors:  Francesca Bursi; Susan A Weston; Jill M Killian; Sherine E Gabriel; Steven J Jacobsen; Véronique L Roger
Journal:  Am J Med       Date:  2007-04-26       Impact factor: 4.965

Review 10.  C-reactive protein and coronary heart disease: a critical review.

Authors:  J P Casas; T Shah; A D Hingorani; J Danesh; M B Pepys
Journal:  J Intern Med       Date:  2008-10       Impact factor: 8.989

View more
  1 in total

1.  Association between multimorbidity and mean platelet volume in diabetic patients with acute myocardial infarction.

Authors:  Bartosz Hudzik; Ilona Korzonek-Szlacheta; Janusz Szkodziński; Radosław Liszka; Andrzej Lekston; Barbara Zubelewicz-Szkodzińska; Mariusz Gąsior
Journal:  Acta Diabetol       Date:  2017-11-30       Impact factor: 4.280

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.